The Biden White House said today that, at a cost of more than $5 billion, it has secured 10 million treatment courses of Pfizer’s COVID-19 oral antiviral drug, contingent on emergency use authorization or approval from the U.S. Food and Drug Administration.
The move is intended to reduce hospitalizations and help curb the pandemic, which is still ongoing after almost two years.
